Zogenix, Inc. (ZGNX) News Headlines

▮ More

Date

Headline

4/9/2019 2:47:55 AM CNCE Hits A Low, UTHR Throws In The Towel On PAH Drug, ZGNX Plunges On FDA Snub

4/8/2019 11:21:43 PM Zogenix Plunges After FDA Refuses To Review Seizure Drug

4/8/2019 5:11:35 PM Zogenix Shares Down 32% After FDA Refuses To Review Seizure Drug

2/6/2019 8:10:24 AM Zogenix Submits NDA To FDA And MAA To European Medicines Agency For FINTEPLA For Dravet Syndrome

12/3/2018 9:23:18 AM Zogenix Reports Positive Phase 3 Trial Results On Efficacy, Safety Of FINTEPLA In Dravet Syndrome

12/2/2018 10:01:43 AM Zogenix Presents Positive Findings On The Impact Of Treatment With FINTEPLA

8/30/2018 8:17:12 AM Zogenix Reports New Data On Impact Of Dravet Syndrome And Other Epileptic Encephalopathies

8/6/2018 5:15:06 PM Zogenix Intends To Offer And Sell 6 Mln Shares In Public Offering

7/13/2018 7:56:09 PM Week Ahead In Pharmaceuticals - 7 Stocks To Watch

7/13/2018 6:30:06 AM Zogenix Inc. (ZGNX) Leaped To A New High On Phase 3 Study Results

7/12/2018 9:44:15 AM Zogenix Inc. (ZGNX) Has Broken Out To A New High On Study Results

7/12/2018 8:01:31 AM ZGNX Hits All-time High On Positive Dravet Syndrome Drug Results

7/12/2018 7:05:15 AM Zogenix Announces Positive Top-line Results From Second Pivotal Phase 3 Clinical Trial Of ZX008 In Dravet Syndrome

7/7/2018 11:03:29 AM Week Ahead In Pharmaceuticals - Stocks To Watch

6/30/2018 2:04:54 AM An Ear To The Pharma: 6 Stocks To Watch (ALKS, ZGNX, ACOR...)

6/1/2018 4:38:00 PM Zogenix Reports Granting Of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

4/25/2018 8:14:05 AM Zogeni Presents New Safety Data From First Pivotal Phase 3 Clinical Trial Of ZX008 In Dravet Syndrome

2/6/2018 8:06:57 AM Zogenix Reports Receipt Of FDA Breakthrough Therapy Designation For ZX008 In Dravet Syndrome

1/19/2018 7:58:33 AM A Rundown Of Dravet Syndrome Drugs In The Pipeline

12/7/2012 6:12:31 PM FDA Panel Rejects Zogenix's Pure Hydrocodone Painkiller Zohydro ER